Archives of Pharmacal Research

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Time Courses of pCREB Expression after Dopaminergic Stimulation by Apomorphine in Mouse Brain

  • Jang, Choon-Gon (Department of Pharmacology, College of Pharmacy, Sungkyunkwan University) ;
  • Lee, Seok-Yong (Department of Pharmacology, College of Pharmacy, Sungkyunkwan University) ;
  • Lee, Han-Kyu (Department of Pharmacology, College of Medicine, Hallym University) ;
  • Suh, Hong-Won (Department of Pharmacology, College of Medicine, Hallym University) ;
  • Song, Dong-Keun (Department of Pharmacology, College of Medicine, Hallym University)
  • Published : 2002.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

Administration of dopamine agonist, apomorphine (2 mg/kg, s.c.), produces cage climbing behavior in mice that exhibit typical dopaminergic stimulation. The present study investigated the pCREB expression level in several brain regions following apomorphine treatment in order to determine whether the increased the dopaminergic activation produced by apomorphine accompanies the changes in pCREB immunoreactivity. A mouse brain was removed at 0min, 10 min, 30 min, 1 h, 2 h, 7 h, and 24 h after apomorphine treatment. The brain tissue was fixed by an intracardiac perfusion with ice-cold 4％ paraformaldehyde in PBS. Immunohistochemical study was conducted using the ABC-DAB method. The data showed that the immunoreactivity of pCREB increased in the striatum, nucleus-accumbens, piriform cortex and the dentate gyrus of the hippocampus of a mouse brain 30 min after the apomorphine treatment. Increased immunoreactivity began to diminish 2 h after the apomorphine treatment in all the brain regions measured. The time course for the pCREB immunoreactivity was similar to the behavioral response induced by the apomorphine treatment. These results suggest that activation of the dopamine receptor is accompanied by an increase in pCREB expression in the mouse brain.

Keywords

References

  1. Albin, R.L., Young, A.B. and Penney, J.B., The functional anatomy of basal ganglia disorders. Trends Neurosci., 12, 366-375 (1989) https://doi.org/10.1016/0166-2236(89)90074-X
  2. Andersson, M., Konradi, C., and Cenci, M.A., cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum. J. Neurosci., 21,9930-9943 (2001)
  3. Cole, A.J., Bhat, R.V., Patt, C., Worley, P.F. and Baraban, J.M., D1 dopamine receptor activation of multiple transcription factor genes in rat striatum. J. Neurochem., 58,1420-1426 (1992) https://doi.org/10.1111/j.1471-4159.1992.tb11358.x
  4. Cole, D.G., Kobierski, LA., Konradi, C. and Hyman, S.E., 6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons. Proc. Natl. Acad. Sci. U. S. A., 91, 9631-9635 (1994) https://doi.org/10.1073/pnas.91.20.9631
  5. Costentin, J., Marcais, H., Protais, P and Schwartz, J.C., (Rapid and prolonged facilitation of stereotyped motor behavior (verticalization) induced by apomorphine in mice previously submitted to stimulation of dopaminergic receptors). C. R. Acad. Sci. Hebd. Seances Acad. Sci. D., 282,913-916 (1976)
  6. Deutch, A.Y., Goldstein, M., Baldino, F., Jr. and Roth, R.H., Telencephalic projections of the A8 dopamine cell group. Ann. N. Y. Acad. sci., 537,27-50 (1988) https://doi.org/10.1111/j.1749-6632.1988.tb42095.x
  7. Fallon, J.H. and Moore, R.Y., Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J. Camp. Neural., 180,545-580 (1978) https://doi.org/10.1002/cne.901800310
  8. Graybiel, A.M., Moratalla, R. and Robertson, H.A., Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. U. S. A, 87, 6912-6916 (1990) https://doi.org/10.1073/pnas.87.17.6912
  9. Homykiewicz, O., Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms. Adv. Neural., 60, 140-147(1993)
  10. Jang, C.G. and Lee, S.y., NMDA-type glutamatergic modulation in dopaminergic activation measured by apomorphine-induced cage climbing behaviors. Arch. Pharm. Res., 24,613-617 (2001) https://doi.org/10.1007/BF02975175
  11. Juncos, J.L., Engber, T.M., Raisman, R., Susel, Z., Thibaut, F., Ploska, A., Agid, Y. and Chase, T.N., Continuous and intermittent levodopa differentially affect basal ganglia function. Ann. Neurol., 25,473-478 (1989) https://doi.org/10.1002/ana.410250509
  12. Kebabian, J.W. and Caine, D.B., Multiple receptors for dopamine. Nature, 277, 93-96 (1979) https://doi.org/10.1038/277093a0
  13. Keefe, K.A. and Gerfen, C.R., D1 dopamine receptor-mediated induction of zif268 and e-fos in the dopamine-depleted striatum: differential regulation and independence from NMDA receptors. J. Camp. Neurol., 367,165-176 (1996) https://doi.org/10.1002/(SICI)1096-9861(19960401)367:2<165::AID-CNE1>3.0.CO;2-3
  14. Kim, H.S., Rhee, G.S., Jung, J.Y., Lee, J.H., Jang, C.G. and Park, W.K., Inhibition by noncompetitive NMDA receptor antagonists of apomorphine-induced climbing behavior in mice. Life Sci., 58, 1397-1402 (1996) https://doi.org/10.1016/0024-3205(96)00109-9
  15. Konradi, C. and Heckers, S., Haloperidol-induced Fos expression in striatum is dependent upon transcription factor cyclic AMP response element binding protein. Neuroscience, 65,1051-1061 (1995) https://doi.org/10.1016/0306-4522(94)00546-H
  16. Konradi, C., Leveque, J.C. and Hyman, S.E., Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium. J. Neurosci., 16,4231-4239 (1996)
  17. Koob, G.F. and Bloom, F.E., Cellular and molecular mechanisms of drug dependence. Science, 242, 715-723 (1988) https://doi.org/10.1126/science.2903550
  18. Paul, M.L., Graybiel, A.M., David, J.C. and Robertson, H.A., D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J. Neurosci., 12,3729-3742 (1992)
  19. Protais, P., Costentin, J. and Schwartz, J.C., Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum. Psychopharmacology (Berl), 50,1-6 (1976) https://doi.org/10.1007/BF00634146
  20. Robertson, H.A., Peterson, M.R., Murphy, K. and Robertson, G.S., D1-dopamine receptor agonists selectively activate striatal c-fos independent of rotational behaviour. Brain Res., 503,346-349 (1989) https://doi.org/10.1016/0006-8993(89)91689-2
  21. Schultz, W., Dayan, P. and Montague, P.R., A neural substrate of prediction and reward. Science, 275,1593-1599 (1997) https://doi.org/10.1126/science.275.5306.1593